skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

atropine > Atropine and hyoscyamine and scopolamine product > Atropine and hyoscyamine and scopolamine only product > Atropine and hyoscine and hyoscyamine only product in oral dose form > Atropine sulfate + hyoscyamine sulfate + scopolamine hydrobromide 0.0194mg/0.1037mg/0.0065mg tablet (product)
Hyoscyamine > Atropine and hyoscyamine and scopolamine product > Atropine and hyoscyamine and scopolamine only product > Atropine and hyoscine and hyoscyamine only product in oral dose form > Atropine sulfate + hyoscyamine sulfate + scopolamine hydrobromide 0.0194mg/0.1037mg/0.0065mg tablet (product)
Scopolamine > Atropine and hyoscyamine and scopolamine product > Atropine and hyoscyamine and scopolamine only product > Atropine and hyoscine and hyoscyamine only product in oral dose form > Atropine sulfate + hyoscyamine sulfate + scopolamine hydrobromide 0.0194mg/0.1037mg/0.0065mg tablet (product)

Preferred term

Atropine sulfate + hyoscyamine sulfate + scopolamine hydrobromide 0.0194mg/0.1037mg/0.0065mg tablet (product)  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Has manufactured dose form

Has presentation strength denominator unit

Has presentation strength numerator unit

Has unit of presentation

URI

http://www.irandoc.acir/onto/irandoc/377219007

Download this concept: